EP1146903A4 - Glypicane zur detektion und behandlung humaner karzinome - Google Patents
Glypicane zur detektion und behandlung humaner karzinomeInfo
- Publication number
- EP1146903A4 EP1146903A4 EP99954963A EP99954963A EP1146903A4 EP 1146903 A4 EP1146903 A4 EP 1146903A4 EP 99954963 A EP99954963 A EP 99954963A EP 99954963 A EP99954963 A EP 99954963A EP 1146903 A4 EP1146903 A4 EP 1146903A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- glypicans
- detection
- treatment
- human carcinoma
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/303—Liver or Pancreas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4725—Proteoglycans, e.g. aggreccan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10451098P | 1998-10-16 | 1998-10-16 | |
US104510P | 1998-10-16 | ||
US12162499P | 1999-02-25 | 1999-02-25 | |
US121624P | 1999-02-25 | ||
PCT/US1999/024176 WO2000023109A1 (en) | 1998-10-16 | 1999-10-15 | Glypicans for the detection and treatment of human carcinoma |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1146903A1 EP1146903A1 (de) | 2001-10-24 |
EP1146903A4 true EP1146903A4 (de) | 2005-02-16 |
Family
ID=26801634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99954963A Withdrawn EP1146903A4 (de) | 1998-10-16 | 1999-10-15 | Glypicane zur detektion und behandlung humaner karzinome |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1146903A4 (de) |
AU (1) | AU769125B2 (de) |
CA (1) | CA2346264A1 (de) |
WO (1) | WO2000023109A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003006611A2 (en) * | 2001-07-12 | 2003-01-23 | Exelixis, Inc. | GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE |
WO2004022597A1 (ja) * | 2002-09-04 | 2004-03-18 | Chugai Seiyaku Kabushiki Kaisha | Gpc3の血中可溶化n端ペプチドに対する抗体 |
ES2324029T3 (es) | 2002-05-23 | 2009-07-29 | Sunnybrook And Women's College Health Sciences Centre | Diagnostico de carcinoma hepatocelular. |
MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
CA2973771A1 (en) * | 2015-01-16 | 2016-07-21 | Minomic International Ltd. | Glypican epitopes and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0162670B1 (ko) * | 1991-01-15 | 1999-05-01 | 마르쿠 잘카넨 | 세포의 악성 전형을 나타내기 위한 조직 및 체액과 같은 생물학적 물질에서의 신데칸 내용물의 검출 |
-
1999
- 1999-10-15 CA CA002346264A patent/CA2346264A1/en not_active Abandoned
- 1999-10-15 WO PCT/US1999/024176 patent/WO2000023109A1/en active IP Right Grant
- 1999-10-15 EP EP99954963A patent/EP1146903A4/de not_active Withdrawn
- 1999-10-15 AU AU11181/00A patent/AU769125B2/en not_active Ceased
Non-Patent Citations (3)
Title |
---|
INKI P ET AL: "THE ROLE OF SYNDECAN-1 IN MALIGNANCIES", ANNALS OF MEDICINE, FINNISH MEDICAL SOCIETY DUODECIM, HELSINKI, FI, vol. 28, 1996, pages 63 - 67, XP002927348, ISSN: 0785-3890 * |
SEBESTYEN A ET AL: "Expression of Syndecan-1 in Human B Cell Chronic Lymphocytic Leukaemia", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 33, no. 13, November 1997 (1997-11-01), pages 2273 - 2277, XP004284563, ISSN: 0959-8049 * |
See also references of WO0023109A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2346264A1 (en) | 2000-04-27 |
EP1146903A1 (de) | 2001-10-24 |
AU1118100A (en) | 2000-05-08 |
WO2000023109A1 (en) | 2000-04-27 |
AU769125B2 (en) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
GB9903841D0 (en) | Diagnosis and treatment of cancer | |
HK1043625A1 (zh) | 腎病檢測及治療 | |
IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
IL128850A0 (en) | Medical treatment | |
AP9700939A0 (en) | Compounds and methods for the treatment of cancer | |
HUP0001316A3 (en) | Method for the detection and localization of malignant human tumours | |
ZA982968B (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
SI1716853T1 (sl) | Zdravljenje rakov äśloveĺ kega telesa z uporabo et743 | |
EP1015038A4 (de) | Verfahren zur entdeckund, behandlung und vorbeugung von neurodegeneration | |
GB9805419D0 (en) | Treatment of liquids | |
GB9811598D0 (en) | Diagnosis and treatment of cancer | |
EP1208191A4 (de) | 13 humane dickdarm- und mit dickdarmkrebs-assoziierte proteine | |
IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
EP1146903A4 (de) | Glypicane zur detektion und behandlung humaner karzinome | |
IL121329A (en) | Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides | |
EP0733365A3 (de) | Verwendung von Benzochinolin-3-one zur Behandlung und Vorbeugung von Prostatkarzinom | |
GB9812550D0 (en) | Tumour therapy and imaging | |
GB9819999D0 (en) | Treatment of cancer | |
IL132531A0 (en) | Detection and therapy of tumors | |
AU2351699A (en) | The human calcium-sensing receptor in the detection and treatment of cancer | |
AU5939898A (en) | Agent for the pre-symptomatic detection, prevention and treatment of breast cancer in humans | |
GB9713189D0 (en) | Appliance for the beauty treatment of parts of the human body | |
EP1007538A4 (de) | Sonden zum nachweis des menschlichen pappillomavirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010426 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050105 |
|
17Q | First examination report despatched |
Effective date: 20080124 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100504 |